Send feedback

LARS2 p.Pro807=

c.2421G>A · rs777901333 · VCV1178480

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.0164%, mid)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP -2GERP -3.4
Overall
CADD3.484PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0164% Middle Eastern · 1/6,084 alleles
Filtering AF 0.00451% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00411%
Overall 0.00508% 82/1,614,040 alleles · ultra-rare exomes 74/1,461,816 · genomes 8/152,224 · joint denominator
Ancestry group Frequency 1 in
Middle Easterngrpmax 0.0164% 6,084
Remaining individualsnot grpmax-eligible 0.0096% 10,414
South Asian 0.00769% 13,012
European (non-Finnish) 0.00559% 17,879
African / African-American 0.00267% 37,473

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
LARS2
Protein
p.Pro807=
Coding
c.2421G>A
MANE Select
NM_015340
dbSNP
rs777901333
Type
single nucleotide variant
Location
chr3:45541845 (GRCh38)
Gene constraint
LOEUF 0.808 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 90.57
Full LARS2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/lars2-p-pro807 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown